Navigation Links
Katherine A. High, M.D., elected to the American Academy of Arts and Sciences
Date:5/10/2011

221.10.254.64

Katherine A. High, M.D., a gene therapy expert at The Children's Hospital of Philadelphia, has been elected to the 2011 class of the American Academy of Arts and Sciences. The Academy is one of the nation's most prestigious honorary societies and is a leading center for independent policy research.

Dr. High joins a select group of scholars, scientists, writers, artists, civic, corporate and philanthropic leaders that includes Nobel laureates, Pulitzer Prize awardees, and winners of MacArthur Fellowships, Oscar Awards and Kennedy Center honors.

A hematologist, Dr. High is internationally recognized for her research on gene therapy, particularly in developing and conducting landmark clinical studies. She has been in the forefront of the effort to develop gene therapy for the inherited bleeding disorder hemophilia and continues to pursue this research. She directs the Center for Cellular and Molecular Therapeutics at Children's Hospital. In 2009, that center sponsored a clinical trial that produced dramatic improvements in children and young adults with Leber's congenital amaurosis, a congenital form of blindness.

Dr. High is a Howard Hughes Medical Institute Investigator and the William H. Bennett Professor of Pediatrics at the University of Pennsylvania School of Medicine. She also is a past president of the American Society of Gene Therapy.


'/>"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
Source:Eurekalert  

Page: 1

Related biology news :

1. Yuemeng Dai, M.D., Ph.D., ear, nose and throat specialist, receives Bill Potsic Basic Science Award
2. Stephen Maturo, M.D., ear, nose and throat specialist, receives Charles Ferguson Award
3. George W. Sledge, Jr., M.D., honored for international contributions to breast cancer research
4. Don Detmer, M.D., receives 2010 Morris F. Collen Award
5. AACR nomination of Harold E. Varmus, M.D., as director of the NCI
6. Gregory Downey, M.D., of National Jewish Health, honored for scientific accomplishments
7. Dr. Marilyn M. Li, M.D., FACMG, is the 2010 Luminex/ACMGF award recipient
8. AACR applauds nomination of Francis S. Collins, M.D., Ph.D., to be the new NIH director
9. Georgetown Universitys Howard J. Federoff, M.D., Ph.D. receives Bernard Sanberg Memorial Award
10. Jonathan Berg, M.D., Ph.D. awarded Richard King Trainee Award for Best in Genetics in Medicine
11. Sihoun Hahn, M.D., Ph.D., FACMG is the 2009-2010 Luminex/ACMGF Award recipient
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Katherine A. High, M.D., elected to the American Academy of Arts and Sciences
(Date:6/22/2016)... 2016  The American College of Medical Genetics and Genomics ... as one of the fastest-growing trade shows during the ... Bellagio in Las Vegas . ... growth in each of the following categories: net square feet ... of attendees. The 2015 ACMG Annual Meeting was ranked 23 ...
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... ... 2016 , ... Newly created 4Sight Medical Solutions ... healthcare market. The company's primary focus is on new product introductions, to include ... are necessary to help companies efficiently bring their products to market. , The ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
Breaking Biology Technology: